Skip to content

Drug interactions

Atogepant + Ergotamine

Severity: Minor

Atogepant and Ergotamine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Atogepant is a CYP3A4 substrate. Ergotamine is not a recognized clinically meaningful CYP3A4 inhibitor, so a relevant rise in atogepant exposure is unlikely.

What this interaction means in plain words

Atogepant and Ergotamine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Atogepant belongs to Central Nervous System; Ergotamine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Ergotamine is a CYP3A4 substrate rather than a established inhibitor; any effect on atogepant is not established.

What to do

No dose change is generally needed; monitor for atogepant adverse effects such as nausea and constipation.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Atogepant and Ergotamine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Atogepant with Ergotamine?

MediHelp rates the interaction as minor. Atogepant and Ergotamine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Atogepant is a CYP3A4 substrate. Ergotamine is not a recognized clinically meaningful CYP3A4 inhibitor, so a relevant rise in atogepant exposure is unlikely.

How serious is the interaction between Atogepant and Ergotamine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is generally needed; monitor for atogepant adverse effects such as nausea and constipation.

What other medicines interact with Ergotamine?

MediHelp also lists interactions of Ergotamine with, for example, Almotriptan, Atazanavir, Clarithromycin. The full list is on the Ergotamine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in